PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

The direct costs of drug-induced skin reactions.

Abstract [b] Abstract Objective.[/b] The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002-2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw. The analysis was carried out from the perspectives of the public payer and service provider. [b]Materials and method. [/b]The retrospective study was carried out in a group of 164 adult patients due to skin adverse drug reactions. Analysis was based on data from patient medical records and medical orders which provided information on the used resources, including diagnostic tests, medical consultations, medicinal products, hospitalisation duration, together with cost estimation, regardless of the treatment being the cause of the skin reaction. [b]Results[/b]. According to the International Statistical Classification of Diseases and Related Health Problems(ICD) diagnosis and scores, assigned by the National Healthcare Fund, it has been estimated that patient hospitalisation at the Department of Dermatology for skin drug reaction incurred costs at the average amount of €717.00 per patient. The complex diagnostics and pharmacotherapy of the same group of patients generated costs for the hospital at the average amount of €680 per patient. [b]Conclusions[/b]. As a result of the analysis, the therapy for skin adverse drug effects generates significant costs, both for the payer and the service provider. Since the costs are comparable, it seems that the pricing of medical procedures by the public payer is adequate for the costs incurred by the medical service provider.
PMID
Related Publications

Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.

Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.

Estimating the unit costs of public hospitals and primary healthcare centers.

Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation.

Authors

Mayor MeshTerms
Keywords

ICD 10

JGP

National Health Fund

adverse drug reactions

direct costs

Journal Title annals of agricultural and environmental medicine : aaem
Publication Year Start




PMID- 28664692
OWN - NLM
STAT- In-Process
DA  - 20170630
LR  - 20170630
IS  - 1898-2263 (Electronic)
IS  - 1232-1966 (Linking)
VI  - 24
IP  - 2
DP  - 2017 May 11
TI  - The direct costs of drug-induced skin reactions.
PG  - 190-193
LID - 72543 [pii]
LID - 10.5604/12321966.1235168 [doi]
AB  - [b] Abstract Objective.[/b] The aim of the study was an assessment of direct
      costs of patients hospitalised for for skin adverse drug reactions during
      2002-2012 in the Department of Dermatology at the Military Institute of Medicine 
      (Ministry of Defence) in Warsaw. The analysis was carried out from the
      perspectives of the public payer and service provider. [b]Materials and method.
      [/b]The retrospective study was carried out in a group of 164 adult patients due 
      to skin adverse drug reactions. Analysis was based on data from patient medical
      records and medical orders which provided information on the used resources,
      including diagnostic tests, medical consultations, medicinal products,
      hospitalisation duration, together with cost estimation, regardless of the
      treatment being the cause of the skin reaction. [b]Results[/b]. According to the 
      International Statistical Classification of Diseases and Related Health
      Problems(ICD) diagnosis and scores, assigned by the National Healthcare Fund, it 
      has been estimated that patient hospitalisation at the Department of Dermatology 
      for skin drug reaction incurred costs at the average amount of euro717.00 per
      patient. The complex diagnostics and pharmacotherapy of the same group of
      patients generated costs for the hospital at the average amount of euro680 per
      patient. [b]Conclusions[/b]. As a result of the analysis, the therapy for skin
      adverse drug effects generates significant costs, both for the payer and the
      service provider. Since the costs are comparable, it seems that the pricing of
      medical procedures by the public payer is adequate for the costs incurred by the 
      medical service provider.
FAU - Kiepurska, Nina
AU  - Kiepurska N
AD  - Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.
FAU - Paluchowska, Elwira
AU  - Paluchowska E
AD  - Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.
FAU - Owczarek, Witold
AU  - Owczarek W
AD  - Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.
FAU - Szkultecka-Debek, Monika
AU  - Szkultecka-Debek M
AD  - Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.
FAU - Jahnz-Rozyk, Karina
AU  - Jahnz-Rozyk K
AD  - Department of Immunology and Allergology, Military Institute of Medicine, Warsaw,
      Poland.
LA  - eng
PT  - Journal Article
PL  - Poland
TA  - Ann Agric Environ Med
JT  - Annals of agricultural and environmental medicine : AAEM
JID - 9500166
OTO - NOTNLM
OT  - ICD 10
OT  - JGP
OT  - National Health Fund
OT  - adverse drug reactions
OT  - direct costs
EDAT- 2017/07/01 06:00
MHDA- 2017/07/01 06:00
CRDT- 2017/07/01 06:00
AID - 72543 [pii]
AID - 10.5604/12321966.1235168 [doi]
PST - ppublish
SO  - Ann Agric Environ Med. 2017 May 11;24(2):190-193. doi: 10.5604/12321966.1235168.